Tuberculosis Trial, Recruiting NCT02527486 Sponsor: Seoul National University Hospital Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT02527486
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with COPD:

  • People who have been diagnosed with COPD, shown by a specific breathing test result (where the airways are significantly narrowed after using a reliever inhaler) and who have ongoing breathing symptoms.

For people with Asthma:

  • People who have never smoked or have smoked very little (fewer than 5 pack-years, which is roughly equivalent to smoking one pack a day for 5 years), who experience repeated asthma symptoms such as wheezing, shortness of breath, chest tightness, or cough, and who have a positive result on at least one of certain breathing tests that confirm airway sensitivity or responsiveness (confirm with trial site).

For people with ACOS (Asthma-COPD Overlap Syndrome):

  • People who meet the criteria for both COPD and Asthma as described above, regardless of their smoking history.

Who may not be able to join:

  • No specific exclusion criteria have been listed for this trial. People interested in participating should contact the trial site directly to confirm whether there are any additional requirements not listed here.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chul-Gyu Yoo, M.D., Seoul National University Hospital

Phone: 82-2-2072-4743

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2011
Est. completion
1 December 2021

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Death (time to death)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov